• 2019-10
  • 2019-11
  • 2020-03
  • 2020-07
  • 2020-08
  • br Pajonk F Riedisser A Henke


    [29] Pajonk F, Riedisser A, Henke M, McBride WH, Fiebich B. The effects of tea extracts on proinflammatory signaling. BMC Med 2006;4:28. [30] Fogh SE, Deshmukh S, Berk LB, Dueck AC, Roof K, Yacoub S, et al. A randomized phase 2 trial of prophylactic manuka honey for the BMS 986120 of chemoradiation therapy-induced esophagitis during the treatment of lung cancer: results of NRGOncologyRTOG1012. Int J Radiat Oncol Biol Phys 2017;97:786–96.
    [31] Hu J, Webster D, Cao J, Shao A. The safety of green tea and green tea extract consumption in adults – results of a systematic review. Regul Toxicol Pharmacol 2018;95:412–33. [32] Kawano Y, Sasaki T, Yamaguchi H, Hirano K, Horiike A, Satouchi M, et al. Phase I/II study of carboplatin plus nab-paclitaxel and concurrent radiotherapy for patients with locally advanced non-small cell lung cancer. Lung Cancer 2018;125:136–41.
    [33] Vokes EE, Herndon 2nd JE, Kelley MJ, Cicchetti MG, Ramnath N, Neill H, et al. Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III Non-small-cell lung cancer: Cancer and Leukemia Group B. J Clin Oncol 2007;25:1698–704.
    [34] Spiro SG, James LE, Rudd RM, Trask CW, Tobias JS, Snee M, et al. Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: a London Lung Cancer Group multicenter randomized clinical trial and meta-analysis. J Clin Oncol 2006;24:3823–30.
    Available online at
    A Qualitative Analysis of the Preoperative Needs of Patients With Papillary Thyroid Cancer
    Susan C. Pitt, MD, MPHS,a,* Elizabeth Wendt, MPH,a,1 Megan C. Saucke, MA,a Corrine I. Voils, PhD,a,b Jason Orne, PhD,c Cameron L. Macdonald, PhD,c Nadine P. Connor, PhD,a and Rebecca S. Sippel, MDa
    a Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin
    b William Middleton Memorial Veterans Hospital, Madison, Wisconsin
    c Qualitative Health Research Consultants, LLC, Madison, Wisconsin
    Article history:
    Accepted 14 June 2019 Available online xxx
    Thyroid cancer
    Patient-doctor relationship
    Background: Thyroid cancer patients report unmet needs after diagnosis. However, little is known about their specific needs. Therefore, we sought to characterize the needs of pa-tients with thyroid cancer before undergoing surgery.
    Material and methods: We conducted semistructured interviews with 32 patients with papillary thyroid cancer after their preoperative surgical consultation. Data were analyzed using thematic content analysis.
    Results: The central need of patients with thyroid cancer was a strong patient-surgeon relationship characterized by informational and emotional support, and respect for the patient as a person. Patients preferred disease- and treatment-related information to be individualized and to take into account aspects of their daily life. They wanted adequate time for asking questions with thoughtful answers tailored to their case. Patients addi-tionally desired emotional support from the surgeon characterized by empathy and vali-dation of their cancer experience. They particularly wanted surgeons to address their fears and anxiety. Patients also highly valued the surgeons’ ability to see beyond their disease and acknowledge them as a unique person with respect to their occupation, psychosocial state, and other individual characteristics. When surgeons met patients’ needs, actin felt reassured, comfortable with their cancer diagnosis, and prepared for treatment. Subopti-mal support increased patients’ anxiety particularly when they felt the surgeon minimized their concerns.
    Conclusions: Preoperatively, patients with thyroid cancer desire a strong patient-surgeon relationship. They rely on the surgeon to provide adequate informational and emotional support and respect them as individuals. In turn, patients feel reassured and prepared for treatment.